Directory

>

Kate Haviland

avatar

Kate Haviland

Chief Executive Officer | Fulcrum Therapeutics

Boston, Massachusetts, United States

View contact details (it's free)

Kate Haviland

Summary

Kate Haviland is an accomplished executive in the biopharmaceutical and biotechnology sectors, currently serving as the Chief Executive Officer at Blueprint Medicines. With a robust background in clinical development and drug commercialization, she has played pivotal roles in leading cross-functional teams to drive innovation in the life sciences. Kate's leadership experience spans multiple high-profile organizations, including serving as Chairman of the Board at Fulcrum Therapeutics. She holds an MBA from Harvard Business School and a BA in Biochemistry/Molecular Biology and Economics from Wesleyan University, reflecting her strong academic foundation. Her expertise encompasses a wide range of areas, including oncology, infectious diseases, and medical devices. Kate is known for her strategic vision and ability to navigate complex market dynamics, making her a respected figure in the industry. In addition to her corporate roles, she has a passion for mentoring emerging leaders in biopharma.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Consulting Experience

Kate Haviland

Work Experience

company logo

Chief Executive Officer at

Blueprint Medicines

April 2022 - Present

company logo

Chairman Of The Board Of Directors at

Fulcrum Therapeutics

June 2018 - Present

company logo

Chief Operating Officer at

Blueprint Medicines

February 2019 - April 2022

company logo

Chief Business Officer at

Blueprint Medicines

January 2016 - February 2019

company logo

Vice President Rare Diseases and Oncology Program Leadership at

Aceragen

April 2014 - December 2015

company logo

Head of Commercial Development at

Sarepta Therapeutics

June 2012 - April 2014

company logo

Executive Director, Commercial Development at

PTC Therapeutics, Inc.

March 2007 - June 2012

company logo

Senior Manager at

Sanofi

January 2006 - January 2007

company logo

Principal, Corporate Development at

Sanofi

January 2005 - January 2006

💼

Consultant at

P.A. Management en Advies B.V.

January 2000 - January 2003

company logo

Associate at

Charles River Associates

January 1998 - January 2000

Logos provided by Logo.dev

Kate Haviland

Education

Harvard Business School

January 2003 - January 2005

Wesleyan University, Ba

January 1994 - January 1998

Frequently Asked Questions about Kate Haviland

What is Kate Haviland email address?

Kate Haviland's primary email address is *********@blueprintmedicines.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Kate Haviland work for?

Kate Haviland is a Chief Executive Officer at Fulcrum Therapeutics, a company specializing in Commercial physical research.

Where Kate Haviland graduated from?

Kate Haviland holds a degree in from Harvard Business School.

How can I directly contact Kate Haviland?

To contact Kate Haviland directly, you can use the email address *********@blueprintmedicines.com. Complete contact information is available upon registration with Muraena.

Who is Kate Haviland?

Kate Haviland is an accomplished executive in the biopharmaceutical and biotechnology sectors, currently serving as the Chief Executive Officer at Blueprint Medicines. With a robust background in clinical development and drug commercialization, she has played pivotal roles in leading cross-functional teams to drive innovation in the life sciences. Kate's leadership experience spans multiple high-profile organizations, including serving as Chairman of the Board at Fulcrum Therapeutics. She holds an MBA from Harvard Business School and a BA in Biochemistry/Molecular Biology and Economics from Wesleyan University, reflecting her strong academic foundation. Her expertise encompasses a wide range of areas, including oncology, infectious diseases, and medical devices. Kate is known for her strategic vision and ability to navigate complex market dynamics, making her a respected figure in the industry. In addition to her corporate roles, she has a passion for mentoring emerging leaders in biopharma.

Kate`s contact details

mail

*********@blueprintmedicines.com

*********@mba2005.hbs.edu

*********@iderapharma.com

Colleagues

avatar
Pamela Mcgowan

Vice President, Head of Talent Acquisition & People Experience

avatar
Bobby Riehle

Vice President, Head of Strategy & Program Lead

avatar
Christine Clemson

SVP, Head of Medical Affairs

Marie-Helene Jouvin

Vice President

avatar
Helge Reisch

Vice President Drug Substance Process Development

avatar
Brian Lucas

Vice President, Head of Medicinal Chemistry

avatar
Jeff Jacobs

Chief Scientific Officer and Head of Technical Operations

Utpal Gupta

Vice President Drug Safety & Pharmacovigilance

avatar
Mel Hayes

Chief Operating Officer

avatar
Alan Musso

Chief Financial Officer

View Contact details (it's free)
Request Profile Removal